Too little mTORC1 activity injures the liver

Area of Science:

• Cellular biology
• Hepatology
• Oncology

Background:

• Obesity is linked to chronic activation of the mechanistic target of rapamycin complex 1 (mTORC1).
• This chronic activation is a known risk factor for liver injury, inflammation, and cancer.
• The role of reduced mTORC1 activity in liver disease is less understood.

Purpose of the Study:

• To investigate the consequences of persistent reduction in hepatic mTORC1 activity.
• To determine if decreased mTORC1 signaling in the liver contributes to liver damage and cancer development.

Main Methods:

• The study by Umemura et al. (2014) likely involved experimental models to manipulate hepatic mTORC1 activity.
• Analysis of liver tissue for markers of cell damage, inflammation, and cancer progression was performed.

Main Results:

• A persistent reduction in hepatic mTORC1 activity was shown to promote liver cell damage.
• Decreased mTORC1 signaling also led to liver inflammation.
• Reduced mTORC1 activity sensitized the liver to cancer development.

Conclusions:

• Both chronic activation and persistent reduction of hepatic mTORC1 activity can be detrimental to liver health.
• Dysregulation of mTORC1 signaling, in either direction, contributes to liver pathology and carcinogenesis.